Theranos has been on quite the roller-coaster ride lately - and it hasn't been pretty. But it looks like the next attempt at reputation and credibility redemption comes in the form of an expanded Medical Advisory Board.
Bioengineers at Rice University have shown in a new study that a single finger-prick blood test really isn't that simple, probably isn't accurate.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.